Published • loading... • Updated
Eloxx Pharmaceuticals, Inc. Announces Pricing of $66.0 Million Public Offering and Uplisting to Nasdaq
- Eloxx Pharmaceuticals announced a public offering of 2,975,000 common stock shares at $11.00 each and pre-funded warrants for 3,025,000 shares at $10.99 each.
- All securities in this offering are being sold directly by Eloxx Pharmaceuticals, which expects to raise gross proceeds of $66.0 million before deducting fees and expenses.
- The company's common stock will begin trading on the Nasdaq Capital Market on June 9, 2026, under the ticker symbol 'ELOX'.
- The offering is planned to close on June 10, 2026, pending standard closing conditions.
Insights by Ground AI
31 Articles
31 Articles
The Conway Daily Sun+30 Reposted by 30 other sources
Eloxx Pharmaceuticals, Inc. Announces Pricing of $66.0 Million Public Offering and Uplisting to Nasdaq
ARLINGTON, Mass., June 8, 2026 /PRNewswire/ -- Eloxx Pharmaceuticals, Inc. (Nasdaq: ELOX) ("Eloxx" and the "Company"), a clinical-stage biopharmaceutical company developing novel, small molecule product candidates designed to modulate the ribosome and promote readthrough of premature stop codons induced by…
Coverage Details
Total News Sources31
Leaning Left5Leaning Right6Center11Last UpdatedBias Distribution50% Center
Bias Distribution
- 50% of the sources are Center
50% Center
L 23%
C 50%
R 27%
Factuality
To view factuality data please Upgrade to Premium
